Merck Loses Patent Infringement Lawsuit against Krka
Ljubljana, 3 September - The Higher Court in Ljubjana has ruled in favour of Slovenian pharmaceutical company Krka, bringing an end to a lawsuit filed by the U.S. pharmaceutical company Merck&Co. The court has dismissed Merck's claim that Krka has been infringing its patent in the production of a generic drug called Enalapril, Krka reported on Tuesday. The ruling is final, and Merck is now only left with the instrument of extraordinary appeal.
The rest of this news item is available to subscribers.
The news item consists of 1.169 characters (without spaces) or 232 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.